4F2 cell-surface antigen heavy chain
4F2 cell-surface antigen heavy chain (also known as 4F2hc or CD98hc) is a protein that in humans is encoded by the SLC3A2 gene. This protein is a type II membrane protein and is a part of the amino acid transporter complex. It plays a crucial role in the regulation of cellular growth and differentiation.
Structure[edit]
The 4F2hc protein is a heavy chain of the heterodimeric amino acid transporters (HATs). It is a type II membrane glycoprotein and has a large extracellular domain, a single transmembrane domain, and a short cytoplasmic tail. The extracellular domain is responsible for the interaction with the light chain subunits, while the cytoplasmic tail is involved in the regulation of cellular signaling pathways.
Function[edit]
The primary function of 4F2hc is to regulate the transport of large neutral amino acids across the cell membrane. It forms a heterodimeric complex with various light chains to transport different amino acids. The 4F2hc-light chain complex is also involved in the regulation of cell growth and differentiation, and it has been implicated in various diseases, including cancer and neurological disorders.
Clinical significance[edit]
Alterations in the expression of 4F2hc have been associated with various types of cancer, including breast cancer, lung cancer, and colorectal cancer. Overexpression of 4F2hc has been shown to promote tumor growth and metastasis. In addition, mutations in the SLC3A2 gene have been linked to certain neurological disorders, such as autism and schizophrenia.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian